GBM

This is an open-label, multi-center Phase 0 study with an expansion phase that will enroll up to 24 participants with newly-diagnosed glioblastoma and up to 18 recurrent glioma...

This study will look at how well 5-ALA, an amino acid compound, can identify cancer cells during surgery and improve tumor removal in patients with high- and low-grade...